FEDERATED HERMES, INC. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$12,605,277
-1.4%
123,751
-2.3%
0.03%
+6.2%
Q2 2023$12,783,884
-2.8%
126,686
-11.4%
0.03%
-3.0%
Q1 2023$13,147,352
+6.2%
142,906
+4.7%
0.03%
-2.9%
Q4 2022$12,385,004
+1.9%
136,519
-14.6%
0.03%
-5.6%
Q3 2022$12,152,000
+0.2%
159,877
+11.4%
0.04%
+9.1%
Q2 2022$12,128,000
-14.7%
143,479
-11.4%
0.03%
+3.1%
Q1 2022$14,216,000
+67.3%
162,000
+66.8%
0.03%
+100.0%
Q4 2021$8,495,000
-11.6%
97,121
-17.4%
0.02%
-11.1%
Q3 2021$9,615,000
-3.5%
117,566
+7.7%
0.02%
-5.3%
Q2 2021$9,963,000
+28.8%
109,197
+20.7%
0.02%
+26.7%
Q1 2021$7,733,000
-11.0%
90,461
-1.7%
0.02%
-16.7%
Q4 2020$8,693,000
+7.3%
92,053
-1.2%
0.02%
-5.3%
Q3 2020$8,100,000
-3.4%
93,144
-2.9%
0.02%
-9.5%
Q2 2020$8,382,000
-17.5%
95,968
-22.1%
0.02%
-30.0%
Q1 2020$10,156,000
+80.7%
123,174
+107.6%
0.03%
+130.8%
Q4 2019$5,620,000
+5.2%
59,344
-3.5%
0.01%0.0%
Q3 2019$5,342,000
-7.0%
61,472
-2.3%
0.01%
-7.1%
Q2 2019$5,747,000
-43.4%
62,937
-40.4%
0.01%
-44.0%
Q1 2019$10,155,000
-22.9%
105,625
-31.2%
0.02%
-30.6%
Q4 2018$13,171,000
-2.1%
153,488
-1.7%
0.04%
+16.1%
Q3 2018$13,460,000
+44.6%
156,215
+26.8%
0.03%
+14.8%
Q2 2018$9,307,000
-10.1%
123,207
-3.8%
0.03%
-10.0%
Q1 2018$10,358,000
-49.8%
128,117
-47.9%
0.03%
-48.3%
Q4 2017$20,626,000
-1.6%
245,676
+0.6%
0.06%
-3.3%
Q3 2017$20,966,000
-8.6%
244,226
-11.1%
0.06%
-9.1%
Q2 2017$22,937,000
-87.0%
274,789
-88.5%
0.07%
-86.9%
Q1 2017$176,720,000
+27.2%
2,379,432
+24.7%
0.50%
+21.2%
Q4 2016$138,965,000
+3014.4%
1,907,815
+3276.1%
0.42%
+3100.0%
Q3 2016$4,462,000
+4.7%
56,510
+9.4%
0.01%
+8.3%
Q2 2016$4,263,000
+22.9%
51,664
+7.9%
0.01%
+9.1%
Q1 2016$3,468,000
-11.9%
47,873
+4.6%
0.01%
-8.3%
Q4 2015$3,936,000
-9.2%
45,755
-3.0%
0.01%
-14.3%
Q3 2015$4,337,000
-39.0%
47,186
-34.7%
0.01%
-33.3%
Q2 2015$7,105,000
+6.2%
72,250
+6.5%
0.02%
+5.0%
Q1 2015$6,689,000
+66.1%
67,836
+56.0%
0.02%
+66.7%
Q4 2014$4,028,000
+32.0%
43,473
+34.1%
0.01%
+20.0%
Q3 2014$3,051,000
+106.7%
32,408
+98.8%
0.01%
+100.0%
Q2 2014$1,476,000
+111.2%
16,304
+98.2%
0.01%
+150.0%
Q1 2014$699,000
+15.3%
8,225
+9.1%
0.00%0.0%
Q4 2013$606,000
+53.4%
7,536
+46.4%
0.00%0.0%
Q3 2013$395,000
-97.2%
5,146
-97.4%
0.00%
-96.4%
Q2 2013$14,125,000199,7490.06%
Other shareholders
NOVARTIS A G shareholders Q3 2023
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders